glp-1 and sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes Obesity Care SMSNA - GLP1 and GLP1/GIP

Description

GLP-1 receptor agonists are a class of medications that mimic a natural hormone in the body

GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy

Beatriz Fernandez-Fernandez made substantial contributions in the design of the work, bibliographic search, drafted the manuscript, reviewed the manuscript, interpretation, discussion and conclusions, contribute to text and contents of the manuscript including revisions and edits and approve of the content of the manuscript and agree to be held accountable for the work

Regular follow-ups, monitoring of hormone levels, and adjustments to treatment, when necessary, provide our patients with a sense of accountability, support, and guidance

A meta-analysis revealed that, compared with the GLP-1R agonists, placebo, and insulin, tirzepatide significantly reduced body mass index, waist circumference, and body weight [75]